BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
BOSTON SCIENTIFIC CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$45.05+0.66 (+1.49%)
Close on Oct 19, 2026
- Market cap
- $66.44B
- P/E (TTM)
- 18.2
- Dividend yield
- –
BOSTON SCIENTIFIC CORP balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 69.9%
- Operating margin
- 19.8%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 1.24
- Debt to equity
- 0.51
- Debt to assets
- 27.9%
- Cash to current liabilities
- 8.4%
Valuation
- P/E ratio
- 18.2
- Price to sales
- 3.16
- Price to book
- 2.67
- Dividend yield
- –